• Explore /
  • Poster
  • / Therapy-relevant gene signatures in the high risk localized renal cell carcinoma setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT).

Therapy-relevant gene signatures in the high risk localized renal cell carcinoma setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT).

Abstract Poster

Authors

null

Phillip M. Rappold

Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY

Phillip M. Rappold , Andrew Silagy , Fengshen Kuo , Mahtab Marker , Albert Reising , John Millholland , Paul Russo , Jonathan Coleman , Martin Voss , Timothy Chan , Robert Motzer , A. Hakimi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 353)

DOI

10.1200/JCO.2021.39.6_suppl.353

Abstract #

353

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: David I. Quinn

First Author: Paul E. Goss

First Author: Toon Van Gorp

First Author: Axel Bex